Traws Pharma (TRAW) announced the appointment of John Leaman, MD, to its board of directors as an independent director, effective October 1, 2025. In addition, Traws’ Board of Directors has eliminated the interim notation of its key executives Iain Dukes and Charles Parker, who are now CEO and CFO, respectively. John Leaman, MD is currently the CFO at Cellarity.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRAW: